Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bd7a45a343acd10e3f5d8775dda2157 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 |
filingDate |
2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44df2c69ff89982bb035e37b83987216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc4aab05f091e32829bc2effcac1c05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef8c75f2c29442cff3e3469a1bd97c6 |
publicationDate |
2010-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201016238-A |
titleOfInvention |
Application of chemokine RANTES togetehr with tumor-associated antigen in a specific time frame for the treatment and/or prevention of cancers |
abstract |
The invention relates to the application of chemokine RANTES together with a tumor-associated antigen in a specific time frame for the treatment and/or prevention of tumors. The invention also relates to a pharmaceutical combination and a kit, which comprise a RANTES gene containing DNA vaccine and a tumor-associated antigen gene containing anti-tumor DNA vaccine. |
priorityDate |
2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |